SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
1518 51 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
585For those of us trying to accumulate more IBRX, this gradual light volume sellofbobbseytwins200167/30/2024
584The good news is that Soon-Shiong is not just a brilliant scientist. When it comghettogoulash17/30/2024
583You've all heard about it, maybe don't believe it, but it's a real tghettogoulash-7/30/2024
582That is exactly what Merck is telling Soon-Shiong. "Look, you are only wortghettogoulash-7/30/2024
581I continue to be surprised and disappointed at the performance of the IBRX stockjargonweary17/29/2024
580Anktiva is not just being sold on the Anktiva website, but on the Cencora OncoloRedman123427/24/2024
579I would expect some rotation out of the bloated, Big Seven tech stocks going forghettogoulash17/12/2024
578Anybody notice the IBB [Nasdaq biotech ETF] breaking out to the upside today aftbobbseytwins200157/11/2024
577Quick note on the Cher history. I am working from 5 year old memory here, but I rallypossum-7/9/2024
576Here is another interesting post from Huggenberg reddit.com Look at his table oEnd2War17/8/2024
575What do you guys think of this post: reddit.comEnd2War47/1/2024
574Our friend trodelvy..will have some help...first cell therapy to show activity icharles39-6/26/2024
573After decades on Wall Street and observing "Hedge Funds" practices andbobbseytwins200166/23/2024
572Laughing over the phonetics of the statute's pronunciation, and the attorneyFitzhughlaw66/23/2024
571Reading your post and sharing your confusion over the short’s thesis here I am rjargonweary36/23/2024
570Galt, regarding PSS' past, I was directed to this article by another sharehoFitzhughlaw26/23/2024
569Anktiva came from Altor Bio, not Sorrento. Used to be called ALT-803, then becamTinfoilHat76/23/2024
568I had been an investor in Sorrento Therapeutics (SRNE) since 2019, but thankfullRedman123446/23/2024
567Is anyone familiar with Carl June, a renowned immunologist from Pennsylvania? Igalt-6/23/2024
566I think that the market shorts are underestimating PSS's commitment here... JJINV-6/22/2024
565I’ve been trying to discern the rationale for the persistence and severity of thFitzhughlaw46/22/2024
564I like it that the headline includes "First Commercial Doses Administered&qFitzhughlaw106/20/2024
563Apologies for being MIA, work and family and kid is too much of a distraction thTinfoilHat46/18/2024
562observertoday.commannamal-6/17/2024
561I'm with ya twins... I need more shares down here... ok, not "need&quJJINV-6/16/2024
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News